Interesting facts
Interesting Facts About (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid
(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid is a compound that belongs to a class of molecules known for their fascinating chemical properties and potential biological applications. Here are some intriguing facts about this compound:
- Structural Complexity: The compound has a complex structure with multiple iodine substitutions which significantly affects its reactivity and biological interactions.
- Therapeutic Potential: With the integration of iodine in its structure, this compound may be explored for its role in medicinal chemistry, particularly in targeting thyroid-related disorders due to iodine's essential role in thyroid hormone synthesis.
- Biological Interest: The phenoxy and diiodophenyl groups attached to the propanoic acid backbone suggest potential interactions with biological receptors, making it of interest in pharmacological research.
- Multi-functional Applications: The presence of hydroxy and amino functional groups implies that this compound could serve multiple purposes, including being a ligand in biochemical assays or as a building block in organic synthesis.
- Motion in the Scientific Community: As research evolves, compounds like this are at the frontier of drug discovery, exploring how halogenated organic compounds can impact therapeutic pathways.
In summary, (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid stands out due to its intricate structure and potential implications in health science. Its continued study could unveil new possibilities in medicine and organic chemistry.
Synonyms
L-thyroxine
levothyroxine
51-48-9
thyroxine
thyroxin
Levothyroxin
Tetraiodothyronine
3,3',5,5'-Tetraiodo-L-thyronine
Thyratabs
Thyreoideum
Thyroxinal
Thyrax
synthroid
Thyroxine iodine
L-Thyroxin
L-T4
3,5,3',5'-Tetraiodo-L-thyronine
Thyroxine (l)
(-)-Thyroxine
Levothyroxine sodium
O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine
levothroid
Levoxyl
3,5,3',5'-Tetraiodothyronine
t4
DL-Thyroxin
Thryroxine, l-
L-3,5,3',5'-Tetraiodothyronine
Thyroxine, L-
Thyroxine (VAN)
eltroxin
Laevothyroxinum
Levothyroxinum (acid)
Laevothyroxinum (acid)
Levothyroxinum
O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine
Tetramet
CCRIS 6739
Forthyron (TN)
HSDB 3108
Synthetic levothyroxine
NSC 36397
3,3',5,5''-Tetraiodo-L-thyronine
Henning
CHEBI:18332
3,5,3'5'-Tetraiodo-L-thyronine
EINECS 200-101-1
UNII-Q51BO43MG4
Prestwick_548
L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-
4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine
BRN 2228515
Q51BO43MG4
3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine
beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine
DTXSID8023214
O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine
(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
MFCD00002595
NSC-36397
3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine
CHEMBL1624
DTXCID603214
THX
SK&F 1-6528
NCGC00164336-01
(S)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid
LT4
LEVOTHYROXINE (USP-RS)
LEVOTHYROXINE [USP-RS]
Levothyroxine;T4
Eutirox
Forthyron
L Thyroxine
(-)-3-(4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)ALANINE
Sodium levothyroxine pentahydrate
SMR000059176
T44
Levothyroxine (BAN)
Levothyroxine [INN:BAN]
Synthroid (*Sodium salt*)
Thyroxine (100% pure T4 reference standard (free of T3))
Thyroxine Cord
SR-01000759430
beta-
2ceo
CAS-51-48-9
Thyroxine (I)
Spectrum_001076
1hk1
1hk2
1hk3
1hk4
1hk5
1y0x
CPD000059176
L-Thyroxine, free acid
L-Thyroxine (Standard)
SpecPlus_000871
THYROXINE [MI]
Prestwick0_000403
Prestwick1_000403
Prestwick2_000403
Prestwick3_000403
Spectrum2_000573
Spectrum3_000611
Spectrum4_000128
Spectrum5_001500
bmse000923
Epitope ID:123889
(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid
LEVOTHYROXINE [HSDB]
BIDD:PXR0161
Levothroid (*Sodium salt*)
SCHEMBL23098
BSPBio_000326
BSPBio_002142
KBioGR_000516
KBioSS_001556
LEVOTHYROXINE [VANDF]
MLS000028647
MLS002548901
DivK1c_006967
SPECTRUM1500774
SPBio_000386
SPBio_002265
LEVOTHYROXINE [WHO-DD]
BPBio1_000360
GTPL2635
O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine
KBio1_001911
KBio2_001556
KBio2_004124
KBio2_006692
KBio3_001642
HMS1569A08
HMS1921I06
HMS2090P18
HMS2092K12
HMS2096A08
HMS2233J18
HMS3259M11
HMS3713A08
L-Thyroxine, >=98% (HPLC)
Pharmakon1600-01500774
Tox21_112101
Tox21_302156
BDBM50301375
CCG-38738
HY-18341R
NSC757434
s2599
AKOS015905129
Tox21_112101_1
AC-7504
CS-1819
DB00451
FL34087
NC00485
NSC-757434
SDCCGMLS-0066571.P001
2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid
3,3'',5,5''-tetraiodo-L-thyronine
3,5,3'',5''-tetraiodo-L-thyronine
NCGC00094852-03
NCGC00164336-02
NCGC00164336-03
NCGC00164336-04
NCGC00164336-05
NCGC00164336-06
NCGC00255368-01
AC-10465
AS-81045
HY-18341
SBI-0051608.P002
DB-006261
NS00067050
SW196731-3
C01829
D08125
D78141
EN300-708765
AB00052176-08
AB00052176_09
AB00052176_10
Q773449
SR-05000001567
LIOTHYRONINE SODIUM IMPURITY A [EP IMPURITY]
SR-01000759430-2
SR-05000001567-1
BRD-K30685142-001-05-5
BRD-K30685142-001-08-9
BRD-K30685142-001-14-7
BRD-K30685142-001-15-4
BRD-K30685142-001-16-2
BRD-K30685142-001-17-0
Thyroxine (T4), IRMM(R) certified Reference Material
L-Thyroxine, powder, BioReagent, suitable for cell culture
L-Tyrosine,O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-
Levothyroxine, United States Pharmacopeia (USP) Reference Standard
(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3, 5-diiodophenyl]propanoic acid
(S)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoicacid
Levothyroxine, Pharmaceutical Secondary Standard; Certified Reference Material
200-101-1
Solubility of (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid
The solubility of a compound can be influenced by various factors, and the solubility of (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid (C15H11I4NO4) is no exception. This complex structure, characterized by its multiple halogen substituents and functional groups, leads to interesting solubility characteristics:
In conclusion, while the (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid may present some solubility in polar solvents due to its functional groups, the overall impact of its iodine content could limit its effectiveness in water. Each solvent's unique properties play a crucial role in determining the compound's solubility.